Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-19-017198
Filing Date
2019-08-20
Accepted
2019-08-20 17:09:55
Documents
4
Effectiveness Date
2019-08-20
Reference 429
333-226782

Document Format Files

Seq Description Document Type Size
1 FORM S-8 dffn20190820_s8.htm S-8 64604
2 EXHIBIT 5.1 ex_155964.htm EX-5.1 11819
3 EXHIBIT 23.1 ex_155965.htm EX-23.1 2745
4 ex_155964img001.gif GRAPHIC 1927
  Complete submission text file 0001437749-19-017198.txt   83356
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-233381 | Film No.: 191040489
SIC: 2834 Pharmaceutical Preparations